The cases affected by coronavirus are on the surge day by day. The Health Department and other frontline workers such as doctors, nurses and other connected people involved seriously day and night in providing medical services to the needy and prevent the spread.
A lot of camps, mobile camps are organised in many areas with specific concentration in cluster areas. Simultaneously, many countries have seriously involved in bringing out a vaccine to find a permanent solution for COVID-19 pandemic to end.
The Novavax organisation in South Africa will be conducting trials on more than 2,500 healthy adults, experiment the safety aspect and immunogenicity on 240 stable HIV positive adults. This effect is in connection with vaccine for coronavirus.
South Africa is already experiencing winter surge of COVID-19 disease, the very important phase of 2b clinical trial trial has the potential to provide an early indication to the possible solution with maximum extra safety and immunogenicity data for the test as per the indications of a Research Chief.
Being the fifth affected country in the world, South Africa recorded nearly 6 lakhs cases and about 12,000 deaths. A foundation organisation is providing a 15 million USD grant for the clinical trials. Novavax inclined to initiated the phase 2 trials with an inclusion of 1,500 candidates. The Company Executive affirmed that it is starting larger late stage clinical trials and potentially bring out sufficient data for obtaining necessary approvals in bringing the vaccine.
In July this year, US awarded 1.6 billion dollars to Novavax towards testing and manufacturing of vaccine with the focus into delivering 100 million doses by January next.
Let us eagerly await for a successful vaccine to eradicate coronavirus, irrespective of the country, which brings out first.
Comments
Post a Comment